Studying at the University of Verona
Here you can find information on the organisational aspects of the Programme, lecture timetables, learning activities and useful contact details for your time at the University, from enrolment to graduation.
Study Plan
This information is intended exclusively for future freshmen who will enroll for the 2026/2027 academic year.If you are already enrolled in this course of study, consult the information available on the course page:
Combined Bachelor's + Master's degree in Pharmacy - Enrollment until 2025/2026The Study Plan includes all modules, teaching and learning activities that each student will need to undertake during their time at the University.
Please select your Study Plan based on your enrollment year.
1° Year
| Modules | Credits | TAF | SSD |
|---|
2° Year It will be activated in the A.Y. 2027/2028
| Modules | Credits | TAF | SSD |
|---|
3° Year It will be activated in the A.Y. 2028/2029
| Modules | Credits | TAF | SSD |
|---|
4° Year It will be activated in the A.Y. 2029/2030
| Modules | Credits | TAF | SSD |
|---|
5° Year It will be activated in the A.Y. 2030/2031
| Modules | Credits | TAF | SSD |
|---|
| Modules | Credits | TAF | SSD |
|---|
| Modules | Credits | TAF | SSD |
|---|
| Modules | Credits | TAF | SSD |
|---|
| Modules | Credits | TAF | SSD |
|---|
| Modules | Credits | TAF | SSD |
|---|
| Modules | Credits | TAF | SSD |
|---|
Legend | Type of training activity (TTA)
TAF (Type of Educational Activity) All courses and activities are classified into different types of educational activities, indicated by a letter.
Pharmacovigilance and Pharmacoepidemiology (It will be activated in the A.Y. 2029/2030)
Teaching code
4S011757
Credits
6
Scientific Disciplinary Sector (SSD)
BIOS-11/A - Farmacologia
Learning objectives
The aim of this course is to provide elements on the use, effectiveness and safety of drugs through pharmacovigilance and pharmacoepidemiology.
At the end of the course the students will know: the National and European legislation on pharmacovigilance; the Italian National Health Service: pharmaceutical assistance; the methodologies for the quantitative and qualitative monitoring of drugs; the application of epidemiological methodologies on the use of drugs; the main mechanisms of side effects, adverse drug reactions (ADRs) and risk factors; ADR spontaneous reporting system and prescribing appropriateness; healthcare utilization databases; strengths and limitations of the spontaneous reporting systems; drug-drug interactions; pharmacovigilance in special populations (e.g., children, elderly, pregnant women); vaccines pharmacovigilance; risk management plan; PSUR; PASS and PAES studies;
reliable sources for drug information; the concepts and methodologies used to carry out pharmacoepidemiology studies; confounders, biases, including exposure and outcome misclassification; to write a study protocol and to interpret study results in pharmacoepidemiology and pharmacovigilance.